abc biopply’s 3D CoSeedis humanized multi-organoid models™ free preclinical models from non-human components whenever possible.
Conventional cellular or animal disease models have shown that the predictability of patient response to treatment is severely limited. Great efforts have been made to humanize mouse models to better predict certain aspects of human physiology and immunology. The abc biopply team has made a significant breakthrough in humanizing upstream 3D cell models through the revolutionary and proprietary 3D CoSeedis in chip communication technology™. Providing optimized physiological growth conditions and unique ways of intercellular communication, our modular models are freed from non-human components whenever possible.
Our 3D CoSeedis humanized multi-organoid models™ revolutionize the field of preclinical studies, offering a powerful and versatile platform for drug discovery and development. With our models, we help you boosting the predictability of in vitro testing to the ex vivo level. Our models accelerate the identification of promising compounds and reduce the reliance on traditional animal models.
3D CoSeedis in chip communication technology™
Revolutionizing the interactive cell-to-cell and organ-to-organ communication